Lobendazole

This classification denotes an antihelminthic agent with the molecular formula C10H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CMF6Z78SWL, chemically known as 2-benzimidazolecarbamic acid, ethyl ester (8ci) but generally known as lobendazole, which bears US NIH Compound Identifier 22752. European Medicines Agency schedules Lobendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08542MIG. The term LOBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). LOBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lobendazole under HS 29339990 and SITC 51577. As of Q4 2014, LOBENDAZOLE remains the US FDA Preferred Term for this commodity. Lobendazole bears US NLM identifiers UMLS ID C0641229 and NCI Concept Code C66023. SMILES: CCOC(=O)NC1=NC2=CC=CC=C2N1.